Candel Therapeutics (CADL) Other Gross PP&E Adjustments (2020 - 2025)

Candel Therapeutics has disclosed Other Gross PP&E Adjustments across 6 years of filings, most recently posting $2.2 million for Q4 2025.

• Other Gross PP&E Adjustments for Q4 2025 came in at $2.2 million, down 42.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (down 42.11% YoY), and the FY2025 annual result was $2.2 million, down 42.11% from the prior year.
• Other Gross PP&E Adjustments came in at $2.2 million for Q4 2025 at Candel Therapeutics, up from $1.9 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.3 million in Q2 2023 to a low of $1.9 million in Q3 2025.
• The 5-year median for Other Gross PP&E Adjustments is $3.7 million (2024), against an average of $3.6 million.
• Across the five-year window, Other Gross PP&E Adjustments soared 47.98% in 2021 and plunged 53.29% in 2025, its largest moves.
• Candel Therapeutics' Other Gross PP&E Adjustments stood at $3.4 million in 2021, then advanced by 7.9% to $3.6 million in 2022, then fell by 8.89% to $3.3 million in 2023, then increased by 12.9% to $3.7 million in 2024, then tumbled by 42.11% to $2.2 million in 2025.
• The last three Other Gross PP&E Adjustments figures came in at $2.2 million (Q4 2025), $1.9 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.